“We could not have done it [vaccine acquisition] differently” and it was “such a fluid area”, said Health Minister Zweli Mkhize during an online discussion with business leaders on Monday.
The event was organised by the Wits Business School and focused on the challenges and opportunities during the Covid-19 vaccine roll-out in South Africa. Mkhize was joined by Professor Shabir Madhi, Cas Coovadia, Dr Ron Whelan and Stavros Nicolau. All have worked with the department in its Covid-19 response.
Mkhize said that in a pandemic, conditions changed constantly and required a lot of consultation and negotiation to make the best of a situation.
India examining vaccine dosage interval and effectiveness after new Covid strain livemint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livemint.com Daily Mail and Mail on Sunday newspapers.
Mutant UK Covid-19 Strain May Force Serum Institute to Tweak Vaccine Composition
FOLLOW US ON:
Serum Institute of India may have to make adjustments in the composition of the vaccine developed by the University of Oxford and British pharma major AstraZeneca after the World Health Organization’s (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) expressed concerns over the effectiveness of the vaccine against the South African mutant coronavirus strain.
According to a report by Mint, on Monday and Tuesday, SAGE reviewed the evidence on the vaccine’s effectiveness on new SARS CoV-2 variants, before making significant recommendations.
Earlier, South Africa decided to stop the rollout of the Oxford-AstraZeneca vaccine after preliminary clinical trial findings published by the Wits Vaccines and Infectious Diseases Analytics Research Unit indicated that it offered minimal protection against the mild-moderate Covid-19 infection from the B.1.351 variant of the coronav
Serum Institute may alter covid shot to tackle mutant strain
Named as covishield in India, the Oxford-AstraZeneca vaccine has been rolled out in the country but is yet to receive a green signal for global use through COVAX
(REUTERS)
on Monday and Tuesday, SAGE reviewed the evidence on jab’s effectiveness on new SARS CoV-2 variants
Share Via
Read Full Story
The composition of the vaccine developed by the University of Oxford and British pharma major AstraZeneca may have to be adjusted by vaccine manufacturer Serum Institute of India, after the World Health Organization’s (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) expressed concerns over the effectiveness of the vaccine against the South African mutant coronavirus strain.
Variant cases in US spike by 73%, with Florida leading the way; CVS, Walgreens to start giving shots Friday: Latest COVID-19 updates Jorge L. Ortiz, Ryan W. Miller and Elinor Aspegren, USA TODAY
How a new type of vaccine called mRNA is changing the game to prevent COVID-19
Replay Video UP NEXT
The number of known coronavirus variant cases in the U.S. has surged 73% in the last week alone, according to figures from the Centers for Disease Control and Prevention released late Tuesday.
The country now reports 944 cases of variants that spread more easily, bypass treatments and immunities, or both.